What is the long-term trend for Palvella Therapeutics's derivative liability, noncurrent?

Over 2 years (2023 to 2025), Palvella Therapeutics's derivative liability, noncurrent has grown at a 41.9% compound annual growth rate (CAGR), from $1.01M to $2.04M.

Palvella Therapeutics PVLA Derivative Liability, Noncurrent

Derivative Liability, Noncurrent at other companies

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesNoncurrent.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's derivative liability, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's derivative liability, noncurrent?: Palvella Therapeutics (PVLA) reported derivative liability, noncurrent of $2.16M in Q1 2026.
How has Palvella Therapeutics's derivative liability, noncurrent changed year-over-year?: Palvella Therapeutics's derivative liability, noncurrent increased by 25.3% year-over-year, from $1.72M to $2.16M.
What is the long-term trend for Palvella Therapeutics's derivative liability, noncurrent?: Over 2 years (2023 to 2025), Palvella Therapeutics's derivative liability, noncurrent has grown at a 41.9% compound annual growth rate (CAGR), from $1.01M to $2.04M.